Marsh & McLennan (MMC) Tops Q1 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Marsh & McLennan (MMC) PT Raised to $210 at RBC Capital
April 19, 2024 6:48 AM EDTRBC Capital analyst Mark Dwelle raised the price target on Marsh & McLennan (NYSE: MMC) to $210.00 (from $208.00) while maintaining a Sector Perform rating.
The analyst comments "MMC's organic growth picked up relative to the past few quarters led by Marsh and Oliver... More
Marsh & McLennan (MMC) PT Lowered to $223 at BofA Securities
April 19, 2024 6:00 AM EDTBofA Securities analyst Joshua Shanker lowered the price target on Marsh & McLennan (NYSE: MMC) to $223.00 (from $228.00) while maintaining a Neutral rating.
The analyst comments "The 9% organic growth in 1Q24 compares favorably vs full-year guidance of mid-single-digits or better and 4Q23 results of +7%. Both... More
Marsh & McLennan (MMC) PT Raised to $213 at Wells Fargo
April 19, 2024 5:57 AM EDTWells Fargo analyst Elyse Greenspan raised the price target on Marsh & McLennan (NYSE: MMC) to $213.00 (from $212.00) while maintaining a Equal Weight rating.
The analyst comments "MMC shares traded up on better organic growth (which improved sequentially), which more than offset a weaker margin.... More
Marsh & McLennan (MMC) PT Raised to $221 at Evercore ISI
April 18, 2024 12:42 PM EDTEvercore ISI analyst David Motemaden raised the price target on Marsh & McLennan (NYSE: MMC) to $221.00 (from $218.00) while maintaining a Outperform rating.
The analyst comments "Bottom line: We think the better underlying revenue growth outweighs the slight margin miss, leading to an overall strong result, especially considering that MMC expects higher margin expansion in 2H24. We increase our EPS ests... More
